Antiretroviral Protease Inhibitors Market Share

On the basis of regional analysis, the anti-retroviral protease inhibitors market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

North America industry is anticipated to hold largest revenue share by 2036, propelled by increasing cases of HIV and chronic HCV, growing industrial sector, and advanced health care infrastructure in the region. Asia Pacific region is expected to register the maximum CAGR during the forecast period, owing to factors such as rising health care expenditure and increasing focus of global pharmaceutical companies on Asia Pacific region. Rise in awareness about the antiretroviral diseases in the Asian and African region will drive the growth of the market.